|By Marketwired .||
|July 25, 2014 06:00 AM EDT||
TORONTO, ONTARIO -- (Marketwired) -- 07/25/14 -- The Centre for Commercialization of Regenerative Medicine's (CCRM) industry consortium is growing with the addition of 13 new companies to its associate membership category. CCRM's industry consortium is now a group of almost 40 companies formed to address bottlenecks in regenerative medicine product pipelines by enabling industry to engage with CCRM's broad network of researchers and institutions.
"CCRM's industry consortium is critical to build a global regenerative medicine nexus in Canada," says Michael May, President and CEO of CCRM. "By establishing collaborative projects with our industry consortium members, we are not only accelerating the development of products to market, but we are also creating jobs."
The following companies have joined CCRM's industry consortium as associate members:
CCRM's industry consortium represents the key sectors in regenerative medicine - therapeutics, devices, reagents, and cells as tools - and tremendous industry experience. To balance the demand for new membership and CCRM's responsibility to maintain an effective and efficient consortium, it has added an associate membership category. The two levels, together, form a strong business network that benefits both academic and industry stakeholders.
For a full list of CCRM's industry consortium and associate members, please visit www.ccrm.ca/industry-consortium.
About the Centre for Commercialization of Regenerative Medicine (CCRM)
CCRM, a Canadian not-for-profit organization funded by the Government of Canada's Networks of Centres of Excellence program and six academic partners, supports the development of technologies that accelerate the commercialization of stem cell- and biomaterials-based technologies and therapies. A network of academics, industry and entrepreneurs, CCRM aims to translate scientific discoveries into marketable products for patients. CCRM launched in Toronto's Discovery District on June 14, 2011. CCRM is hosted by the University of Toronto.
CCRM focuses on three core development themes: cell reprogramming and engineering; cell manufacturing; and, biomaterials and devices to carry out projects commissioned by academia and industry. CCRM has a fully resourced, 6,000 square foot development facility where all development work takes place.
Aug. 25, 2016 03:30 AM EDT Reads: 2,110
Aug. 25, 2016 02:30 AM EDT Reads: 2,140
Aug. 25, 2016 02:15 AM EDT Reads: 457
Aug. 25, 2016 02:00 AM EDT Reads: 1,776
Aug. 25, 2016 02:00 AM EDT Reads: 1,891
Aug. 25, 2016 01:15 AM EDT Reads: 1,602
Aug. 25, 2016 01:00 AM EDT Reads: 1,972
Aug. 25, 2016 12:45 AM EDT Reads: 1,903
Aug. 25, 2016 12:30 AM EDT Reads: 2,073
Aug. 25, 2016 12:00 AM EDT Reads: 2,975
Aug. 24, 2016 10:30 PM EDT Reads: 1,458
Aug. 24, 2016 10:30 PM EDT Reads: 2,012
Aug. 24, 2016 09:15 PM EDT Reads: 1,673
Aug. 24, 2016 04:45 PM EDT Reads: 1,326
SYS-CON Events announced today that Venafi, the Immune System for the Internet™ and the leading provider of Next Generation Trust Protection, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Venafi is the Immune System for the Internet™ that protects the foundation of all cybersecurity – cryptographic keys and digital certificates – so they can’t be misused by bad guys in attacks...
Aug. 24, 2016 04:15 PM EDT Reads: 2,559